Please login to the form below

Not currently logged in
Email:
Password:

ABPI appoints Pfizer’s Colette Goldrick as first Northern Ireland director

Will develop relationships with key opinion leaders in region

ABPI Colette GoldrickThe Association of the British Pharmaceutical Industry (ABPI) has appointed Pfizer Europe's former head of head of public affairs and policy Colette Goldrick as its first Northern Ireland director.

A native of Northern Ireland, Goldrick will be tasked with the identification, establishment and development of relationships with key opinion leaders and decision makers in the nation.

“The ABPI believes that Northern Ireland represents a significant opportunity for the bio-pharmaceutical industry in terms of the growing life science agenda, arising from world class capability at Queen's University Belfast, the University of Ulster and the Science Park,” said the ABPI's chief executive Stephen Whitehead.

“Our partnership based approach will seek to engage all stakeholders in supporting healthcare professionals to effectively utilise innovative medicines and improve patient health.”

Goldrick has a strong pedigree within the pharma industry, serving in senior positions in public affairs and communications at both Pfizer and GlaxoSmithKline.

Prior to her most recent role at Pfizer, she was Pfizer UK's head of communications and corporate affairs director. During her time at the pharma giant, she won Communiquétor of the Year at the Communiqué Awards 2008. At GSK, Goldrick served in several roles, rising to head of communications.

6th November 2012

From: Sales, Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

Measures for measures
Why pharma’s marketing metrics must close the loop...
Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...
Brain scan
Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...

Infographics